Health ❯ Healthcare ❯ Medical Research

Neurology

Alzheimer's Disease Dementia Parkinson's Disease Epilepsy Biomarkers Stroke Neurodegenerative Diseases Migraine Treatment Multiple Sclerosis Amyotrophic Lateral Sclerosis

4 ARTICLES

2w ago

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

Recent studies find plasma p‑tau217 best detects clinical Alzheimer’s while amyloid‑beta misfolding and combined marker panels identify risk years earlier, shaping screening and trial approaches.

3 ARTICLES

4w ago

34‑circRNA Blood Signature Outperforms pTau217 in Detecting and Predicting Alzheimer’s

3 ARTICLES

last mo.

Brockman Family Donates $110 Million to Houston Methodist, New Tower to Carry Their Name

5 ARTICLES

last mo.

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

3 ARTICLES

2mo ago

Glucosamine Linked to Faster Dementia Progression and Higher Death Risk, Study Finds

7 ARTICLES

2mo ago

Glucosamine Linked to Faster Progression and Higher Death Rates in Alzheimer’s Patients

16 ARTICLES

2mo ago

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

4 ARTICLES

3mo ago

Study Identifies Switch That Halts Post‑Stroke Repair, Prolongs Recovery in Mice

3 ARTICLES

3mo ago

Migraine CGRP Drugs Tied to Lower Glaucoma Risk in Neurology Study

3 ARTICLES

3mo ago

Mayo Clinic Study Finds Autism Far More Common in Children With Epilepsy

3 ARTICLES

3mo ago

Common Blood Test Marker Linked to Higher Future Dementia Risk, Large Study Finds

21 ARTICLES

4mo ago

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

9 ARTICLES

4mo ago

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

5 ARTICLES

4mo ago

Blood Test Detects Alzheimer’s Risk Years Before PET Scans

3 ARTICLES

4mo ago

Meta-Analysis Finds No Link Between Hormonal Birth Control and Idiopathic Intracranial Hypertension

3 ARTICLES

4mo ago

CSF Enzyme Marker Distinguishes Parkinson’s and Lewy Body Dementia From Alzheimer’s

Neurology

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

Donanemab Slows Alzheimer's Decline, New AAIC Data Show

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

34‑circRNA Blood Signature Outperforms pTau217 in Detecting and Predicting Alzheimer’s

Brockman Family Donates $110 Million to Houston Methodist, New Tower to Carry Their Name

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

Glucosamine Linked to Faster Dementia Progression and Higher Death Risk, Study Finds

Glucosamine Linked to Faster Progression and Higher Death Rates in Alzheimer’s Patients

Never miss stories about

Neurology

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

Study Identifies Switch That Halts Post‑Stroke Repair, Prolongs Recovery in Mice

Migraine CGRP Drugs Tied to Lower Glaucoma Risk in Neurology Study

Mayo Clinic Study Finds Autism Far More Common in Children With Epilepsy

Common Blood Test Marker Linked to Higher Future Dementia Risk, Large Study Finds

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

Blood Test Detects Alzheimer’s Risk Years Before PET Scans

Meta-Analysis Finds No Link Between Hormonal Birth Control and Idiopathic Intracranial Hypertension

CSF Enzyme Marker Distinguishes Parkinson’s and Lewy Body Dementia From Alzheimer’s

Never miss stories about

Neurology